[Study of biological markers of pulmonary fibrosis with clinical peplomycin or radiotherapy].
D001761:Bleomycin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008054:Lipid Peroxides / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood* / Q000628:therapy; D008297:Male; D017663:Peplomycin; D010446:Peptide Fragments / Q000097:blood; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D010743:Phospholipids / Q000097:blood; D011347:Procollagen / Q000097:blood; D011658:Pulmonary Fibrosis / Q000175:diagnosis* / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D013736:Testicular Neoplasms / Q000097:blood / Q000628:therapy
D008054:Lipid Peroxides; D010446:Peptide Fragments; D010743:Phospholipids; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D001761:Bleomycin; D017663:Peplomycin; D007703:Peptidyl-Dipeptidase A